Citius Oncology Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.65

-0.04 (-5.96%)

As of Jun 30, 10:33 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +4,813.1% upside

Low Target $22.24

Average Target $31.94

High Target $42.20

Current Price $0.65

Current
$0.65

Target
$31.94

$22.24 $31.94 avg $42.20

Scenario Analysis

Bear Case

$22.24

3,321.0%

Low target

Base Case

$31.94

+4,813.1%

Avg target

Bull Case

$42.20

+6,391.3%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$6.19

-89.5% from high

52-Week Low

$0.49

+32.4% from low

Target vs 52W High

$31.94

+416.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%